| Title |
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
|
|---|---|
| Published in |
Journal of Autism and Developmental Disorders, November 2016
|
| DOI | 10.1007/s10803-016-2946-7 |
| Pubmed ID | |
| Authors |
Jeanne M. Madden, Matthew D. Lakoma, Frances L. Lynch, Donna Rusinak, Ashli A. Owen-Smith, Karen J. Coleman, Virginia P. Quinn, Vincent M. Yau, Yinge X. Qian, Lisa A. Croen |
| Abstract |
This study examined psychotropic medication use among 7901 children aged 1-17 with autism spectrum disorder (ASD) in five health systems, comparing to matched cohorts with no ASD. Nearly half (48.5 %) of children with ASD received psychotropics in the year observed; the most common classes were stimulants, alpha-agonists, or atomoxetine (30.2 %), antipsychotics (20.5 %), and antidepressants (17.8 %). Psychotropic treatment was far more prevalent among children with ASD, as compared to children with no ASD (7.7 % overall), even within strata defined by the presence or absence of other psychiatric diagnoses. The widespread use of psychotropics we observed, particularly given weak evidence supporting the effectiveness of these medications for most children with ASD, highlights challenges in ASD treatment and the need for greater investment in its evaluation. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 17% |
| Mexico | 2 | 11% |
| Australia | 1 | 6% |
| United Kingdom | 1 | 6% |
| Chile | 1 | 6% |
| Spain | 1 | 6% |
| Canada | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 72% |
| Scientists | 4 | 22% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 132 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 14% |
| Researcher | 17 | 13% |
| Student > Bachelor | 15 | 11% |
| Student > Ph. D. Student | 13 | 10% |
| Student > Doctoral Student | 10 | 8% |
| Other | 24 | 18% |
| Unknown | 34 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 32 | 24% |
| Medicine and Dentistry | 21 | 16% |
| Social Sciences | 11 | 8% |
| Nursing and Health Professions | 10 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Other | 18 | 14% |
| Unknown | 36 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2016.
All research outputs
#1,750,207
of 24,855,923 outputs
Outputs from Journal of Autism and Developmental Disorders
#717
of 5,389 outputs
Outputs of similar age
#31,072
of 318,033 outputs
Outputs of similar age from Journal of Autism and Developmental Disorders
#13
of 66 outputs
Altmetric has tracked 24,855,923 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,389 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,033 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.